WILMINGTON, NC – New Hanover Regional Medical Center is pleased to announce the launch of the NHRMC Endovascular Stroke Program to offer a new therapy for stroke patients.
Stroke is a leading cause of disability and death in our region, and each year more than 690,000 Americans suffer a stroke caused by the blockage of an artery by a blood clot. Endovascular therapy is a minimally invasive procedure done to remove the clot by inserting a catheter through the blood vessel. Patients receiving this treatment typically have a shorter recovery time and less post-stroke disability.
“This program is transformative for the residents of southeastern North Carolina,” said James McKinney, MD director of the NHRMC Stroke Center. “Time is the most important factor when dealing with a stroke and beginning this treatment as soon as possible close to home means better outcomes for our patients.”
NHRMC Stroke Center consists of a team of physicians, pharmacists, nurses, led by:
• James McKinney, MD
, Director, NHRMC Stroke Center
• Vinodh Doss, DO
, Medical Director of Interventional Neurology
• Matthew Kalp, MD, PhD
, Hospital Neurology
The NHRMC Stroke Center has received the highest quality recognition given by the American Heart Association/American Stroke Association for two years in a row. NHRMC’s Stroke Program treats about 900 stroke patients each year. More information on endovascular stroke and the NHRMC Stroke Program visit www.nhrmc.org/stroke